Is COR stock a Buy, Sell, or Hold?

Based on our analysis, COR is currently a HOLD with moderate confidence. 📊 HOLD: COR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of COR stock?

Our analysis estimates the fair value range for COR to be between $268.96 and $285.32. The current price is $296.51.

What is the analyst price target for COR?

The average Wall Street analyst price target for COR is $351.00. This implies a potential upside of 18.4% from current levels.

COR Stock Analysis: Buy, Sell, or Hold?

COR - Cencora, Inc.

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

$296.51

8.09 (2.80%) ▲

5d: +3.33%

30d: +11.96%

90d: -6.66%

HOLD

MODERATE Confidence

Protect Your COR Gains

Analysis Updated: Jul 2, 2026 12:00 AM ET

Earnings: Aug 05, 2026

Get Alerted When COR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: COR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 11.4%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$478.26

Based on 7.7% avg growth

INTRINSIC VALUE TODAY

$296.96

0.2% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: COR is currently trading at $296.51, which is considered extended relative to its 30-day fair value range of $268.96 to $285.32. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.0) compared to its historical average (16.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.6% over the next few years. This pessimistic expectation contrasts with the company's recent 128.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, COR is in a strong downtrend. The price is approaching resistance at $284.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: COR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $351.00 (+18.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $268.96 - $285.32

Company Quality Score 64/100 (BUY)

Volume Confirmation HIGH

Confidence Score 59.5%

Protect Your Profits

Holding COR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BULLISH: Strong technical setup (75/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($351.00)

Trading Range Analysis

30-Day Trading Range $268.96 - $285.32

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $266.72

Resistance Level $284.93

Current Trend Strong Downtrend

Technical data as of Jun 17, 2026

Fundamental Context

Forward P/E (Next Year Est.) 14.98

Wall Street Target $351.00 (+18.4%)

Revenue Growth (YoY) 3.8%

Earnings Growth (YoY) 128.3%

Profit Margin 0.8%

Valuation Discount vs History -3.6% cheaper

PE vs Historical 15.0 vs 16.7 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -3.6% (market-implied from PE analysis)

1-Year Target $285.84 (-4%)

2-Year Target $275.55 (-7%)

3-Year Target $265.63 (-10%)

3-Yr Target (if PE normalizes) (PE: 15→17) $296.11 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 21.8, Growth: 11.4%) $595.47 (+101%)

Base: (SPY PE: 15.0, Growth: 11.4%) $409.58 (+38%)

Bear: (PE: 12.7, Growth: 11.4%) $348.14 (+17%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (15x PE) as earnings recover.

Trailing PE: 22.12 | Current EPS (TTM): $13.04

Bull Case $481.56 (+62%)

Analyst growth 51.8%, PE expands to 24.3

Base Case $437.78 (+48%)

Market implied 51.8%, PE stable at 22.1

Bear Case $196.13 (-34%)

Severe decline -20.0%, PE contracts to 18.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 15.0 to 16.7

Stabilization Target: $330.54 (+11.5%)

PE Expansion Potential: +11.5%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: July 04, 2026 12:52 AM ET
Data refreshes hourly during market hours. Next update: 1:52 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is COR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Ro Khanna SELL 2026-03-30

Ro Khanna SELL 2026-03-23

Ro Khanna BUY 2026-01-29

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for COR.

Create Free Account

Already have an account? Log In

Top Rated Medical Distribution Stocks

Top-rated stocks in Medical Distribution by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
MCK McKesson Corporation	STRONG BUY 17 analysts	$941	60 HOLD
CAH Cardinal Health Inc	BUY 17 analysts	$245	62 BUY
HSIC Henry Schein Inc	HOLD 16 analysts	$88	63 BUY
QIPT Quipt Home Medical Corp	STRONG BUY 5 analysts	$4	53 HOLD
OMI Owens & Minor Inc	HOLD 6 analysts	$6	53 HOLD

MCK McKesson Corporat…

60 HOLD

CAH Cardinal Health I…

62 BUY

HSIC Henry Schein Inc

63 BUY

QIPT Quipt Home Medica…

53 HOLD

OMI Owens & Minor Inc

53 HOLD

Advanced COR Option Strategies

Professional options setups generated by AI based on today's COR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for COR

COR Technical Chart COR Price Prediction COR Earnings Date COR Investment Advisor COR Fair Price Analyzer COR Options Advisor COR Options Chain COR Options Analysis COR Competitors

Compare COR with Peers

COR vs DLR
Which one to buy?

COR vs EQIX
Which one to buy?

COR vs EXR
Which one to buy?

COR vs CPT
Which one to buy?

COR vs ARE
Which one to buy?

MCK vs COR
Winner: MCK

COR vs EXR
Winner: COR

Create New Comparison View All Competitors

Tradestie